https://www.biospace.com/bayer-bets-big-on-askbio-s-gene-therapy-platform-acquires-company-for-up-to-4-billion
As part of our strategy, we are building new therapeutic platforms including cell and gene therapies,” Stefan Oelrich, president of the Bayer’s Pharmaceuticals Division said in a statement